SecBot SecBot
SC 13G/A ·Filed Nov 13, 2026

URGN

UroGen Pharma Ltd.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3d 9h ago SEC0000947263-26-000091
Passive stake amendment
Actionable Insight • Neutral

A passive holder reducing its stake is routine and not a signal of changing fundamentals. Monitor next 13F for broader institutional positioning trends, but this filing alone does not indicate a shift in investment thesis.

DirectionNeutral
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Toronto Dominion Bank filed an amended Schedule 13G disclosing a reduced passive stake in UroGen Pharma of 2,886,236 shares (5.9% of outstanding shares) as of September 30, 2026, down from 6.3% reported by BlackRock in the prior filing. The decrease reflects routine portfolio adjustments by a passive institutional holder.

Key Financial Metrics

Stake
5.9%
Investor
Toronto Dominion Bank

Key Facts

  • Toronto Dominion Bank (TD Bank) and its subsidiary TD Securities Inc. filed an amended Schedule 13G for UroGen Pharma Ltd.
  • As of September 30, 2026, TD Bank beneficially owned 2,770,530 shares and TDSI owned 115,706 shares, for a combined 2,886,236 shares.
  • The combined stake represents 5.9% of UroGen's outstanding ordinary shares.
  • This is a decrease from the prior filing (BlackRock's 6.3% stake as of September 30, 2026), though the prior filing was by a different filer; TD Bank's own prior stake is not provided in the documents.
  • TD Bank disclaims beneficial ownership of TDSI's shares except to the extent of its pecuniary interest.
  • The filing certifies the securities were acquired and are held in the ordinary course of business, not with the purpose of changing or influencing control.

Financial Impact

TD Bank's combined stake of 2,886,236 shares valued at approximately $167M based on $1.3B market cap and 5.9% stake.

ownership_percentage

Risk Factors

  • No material risks identified from this routine passive stake amendment.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0000947263-26-000091
Document: 0000947263-26-000091-index.html0000947263-26-000091
Document: 0000947263-26-000091.txt0000947263-26-000091

Track record

16 reports on URGN

Performance horizon

5 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +54.89% at T+60 after the Mar 2, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Viewing Entry $25.90 Now $28.10 +8.49% settles Nov 23
  2. Nov 4, 202612d ago 8-K Neutral 5/10 No price data
  3. Nov 4, 202612d ago Press Release Bearish 6/10 Entry $28.74 to $26.10 Now $28.10 +2.23% ▲ +9.19% +8.27% vs SPY
  4. Nov 2, 202614d ago Press Release Neutral 4/10 Entry $34.36 to $26.31 Now $28.10 −18.22% ▼ −23.43% −23.51% vs SPY
  5. Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $33.75 to $28.74 Now $28.10 −16.74% ▼ −14.84% −14.13% vs SPY
  6. Oct 19, 202628d ago Press Release Bullish 6/10 Entry $34.15 to $34.23 Now $28.10 −17.72% ▲ +0.23% +0.38% vs SPY
  7. Oct 9, 20265w ago 144 Neutral 2/10 Entry $36.83 to $34.56 Now $28.10 −23.70% ▼ −6.16% −4.20% vs SPY
  8. Sep 9, 20269w ago Insider Cluster Neutral 2/10 Entry $45.00 to $43.04 Now $28.10 −37.56% ▼ −4.36% −4.02% vs SPY
  9. Aug 20, 202612w ago 8-K Neutral 4/10 Entry $46.80 to $45.50 Now $28.10 −39.96% ▼ −2.78% −3.89% vs SPY
  10. Aug 5, 202614w ago 8-K Bullish 7/10 Entry $46.43 to $49.00 Now $28.10 −39.48% ▲ +5.54% +5.18% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens in 6h 33m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026